Nonclinical Evaluation of Endocrine-Related Drug Toxicity
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 9, 2015
May 14, 2020
3925c81a-41d1-4ab8-a0da-0aec3f634c05
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Uncomplicated Gonorrhea: Developing Drugs for Treatment
Guidance DocumentAugust 18, 2015Center for Drug Evaluation and Research
Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment
Guidance DocumentNovember 2, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.